Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CHAT | P28329 | 2/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3654206 | 1.00 | MAOB (0.46) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL2657529 | 1.00 | MAOB (0.46) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL27372971 | 0.97 | MAOB (0.43) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL28054656 | 0.85 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPK1L3MBTL1TDP1 | |
| SCHEMBL6330351 | 0.82 | MAOB (0.56) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL6330348 | 0.82 | MAOB (0.56) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL3949316 | 0.77 | — | — | |
| SCHEMBL627659 | 0.76 | MAOB (0.74) | MAOBALDH1A1TRPA1LMNAALOX5 | |
| SCHEMBL9454821 | 0.76 | MAOB (0.74) | MAOBALDH1A1TRPA1LMNAALOX5 | |
| SCHEMBL21457949 | 0.76 | MAOB (0.74) | MAOBALDH1A1TRPA1LMNAALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020119909-A1 | Preparation of enantiomerically enriched flavor and fragrance components | RHODIA CHIREX, INC. | 2002-08-29 | — | — | US | disclosed |
| WO-2002057227-A2 | PROCESS OF ENANTIOMERICALLY ENRICHED FLAVOR AND FRAGRANCE COMPONENTS | RHODIA/CHIREX, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119909-A1 | Preparation of enantiomerically enriched flavor and fragrance components | NISCH, FASTKD5, NOTUM | MAOB 530/4885ALDH1A1 328/4885TSHR 4515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.